NSEPress Release11 Sept 2026 · 11 Sept 2026, 08:46 pm

Press Release

Vijaya Diagnostic Centre Limited · VIJAYA

✦ AI Summary▲ PositiveM&A

Vijaya Diagnostic Centre Limited has acquired 100% of Arya Wellness Centre, a B2C focused integrated diagnostic centre in Guwahati, Assam, for ₹46 Cr. This acquisition marks Vijaya's entry into the North-East India diagnostics market and strengthens its presence in Eastern India.

Analysis Scores

Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated September 11, 2026, titled "100% acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam.".

Attachments (1)

📄

VIJAYA_11092026204548_Stx_VDCL_PR_Signed.pdf

pdf

Download →
View document text
September 11, 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Subject: Press Release – Strategic Acquisition / Business Transfer Agreement (BTA) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our earlier outcome disclosure dated September 11, 2026, we are enclosing herewith a copy of the Press Release being issued by the Company regarding the execution of the Business Transfer Agreement (BTA) for the 100% acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Assam on a slump sale basis from NEMRIL HRPL JV (North Eastern Medical Research Institute Limited – Hexagon Research Private Limited JV). Kindly take the same on record. Thanking You. Yours Faithfully For Vijaya Diagnostic Centre Limited Narasimha Raju K A Chief Financial Officer Encl.: As above Regd. Office - 6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana, India Vijaya Diagnostic Centre Makes Strategic Foray into Assam, Strengthening its Eastern India Presence through the Acquisition of B2C Focused Integrated Diagnostic Centre, Arya Wellness Centre in Guwahati India, Hyderabad, 11th September 2026: Vijaya Diagnostic Centre Limited (NSE: VIJAYA | BSE: 543350), India’s leading Integrated Diagnostic Chain, today announced 100% acquisition of a well-established B2C focused integrated diagnostic centre, Arya Wellness Centre in Guwahati, Assam through a Business Transfer Agreement (BTA) for a consideration of ~INR 46 Cr. marking the Company’s entry into the North-East India diagnostics market. The transaction is expected to close within ~ three months, subject to the fulfilment of customary Conditions Precedent (CPs) and other terms and conditions as set out in the BTA. Aligned with Vijaya’s long-term growth strategy and its core principles of B2C-focused businesses, an integrated ‘All Under One Roof’ model and strategic geographic expansion, the transaction is a natural fit for the Company. It complements Vijaya’s growing presence in West Bengal and extends its proven concentric-circles approach into the North-East, creating a strategic platform for further expansion across the region. A Strategic Entry into an Attractive New Geography Guwahati serves as the principal healthcare hub for Assam and the wider North-East region, catering not only to the city but also to patients travelling from neighbouring districts and states for advanced healthcare services. The acquisition provides Vijaya with an established operating platform in this attractive market. Established in 2021, as a Joint Venture / AOP between North-Eastern Medical Research Institute Ltd. (NEMRIL), and Hexagonal Research Pvt. Ltd. (HRPL), Arya Wellness Centre is a leading B2C focused integrated diagnostic centre located in GS Road in the heart of the Guwahati’s prominent healthcare hub surrounded by several leading hospitals. It offers a comprehensive suite of diagnostic services across radiology and pathology, with capabilities spanning MRI, CT, ultrasound, mammography, X-ray, pathology tests and specialised services including high-end interventional radiology procedures and histopathology. The business, which operates a single centre, has built a strong B2C business, with over 85% of its revenues generated from the B2C segment, supported by an experienced team of doctors with strong clinical credentials. In FY26, the business recorded revenue from operations of ~₹26 cr. (Business Mix: 56% comes from Pathology and balance 44% comes from Radiology) with IND AS EBITDA of ₹5.6 cr. and IND AS Adjusted PAT of ₹2.5 cr. Commenting on the acquisition, Ms. Suprita Reddy, Managing Director & CEO, Vijaya Diagnostic Centre Limited, said: Our entry into Guwahati marks another important milestone in Vijaya’s journey towards building a high- quality, integrated diagnostics network. We have consistently pursued a disciplined approach to expansion, focusing on markets with strong long-term demand for comprehensive and advanced diagnostic services. Guwahati is a natural strategic extension of our growing presence in West Bengal and provides an attractive gateway to the North-East. Arya Wellness Centre has been built on an ethos that closely aligns with Vijaya’s philosophy of delivering high-quality diagnostics. It is a unique asset in Guwahati with a balanced mix of advanced and basic pathology and radiology services, making it a strategically attractive asset for us. We believe this acquisition provides Vijaya with a strong platform to establish a meaningful presence in Assam and progressively expand across the North-Eastern region. Page | 1 Mr. Narasimha Raju KA, Chief Financial Officer, Vijaya Diagnostic Centre Limited, said: The acquisition reflects our disciplined approach to capital allocation and our focus on pursuing opportunities that create long-term shareholder value. The transaction has been concluded through a slump sale structure by execution of a Business Transfer Agreement (BTA) at valuation of ~8–9x of FY26 IND AS EBITDA and is expected to be EPS accretive from the outset. Importantly, the acquisition provides us with an established and profitable operating base in Guwahati while maintaining our focus on capital efficiency and return thresholds. The Company will continue to evaluate both organic and inorganic opportunities where it sees the potential to combine strong market fundamentals, strategic fit, attractive valuations and healthy long-term returns on invested capital. Mr. Siva Rama Raju Vegesna, Chief Operating Officer, Vijaya Diagnostic Centre Limited, said: Arya Wellness Centre brings together a strong B2C business with comprehensive radiology and pathology capabilities, and an experienced clinical team, making it a strategic fit with Vijaya’s integrated diagnostics model. Our immediate focus will be on ensuring a seamless transition, strengthening the team, and ensuring the continuity of patient care and service quality. Over time, we look forward to leveraging Vijaya’s operating expertise, clinical capabilities and established processes to build upon our presence in Guwahati and support our calibrated expansion across Assam and the broader North-East region. About Vijaya Diagnostic Centre Limited Vijaya Diagnostic Centre Limited (Vijaya), is one of India’s largest integrated diagnostic chains, providing one-stop solution for pathology and radiology investigations through an extensive operational network spanning 160+ diagnostic centres and 27 reference laboratories in 27 cities and towns spread across Telangana, Andhra Pradesh, Maharashtra, Karnataka, NCR and West Bengal. The company offers comprehensive diagnostic services ranging from basic pathology to high-end radiology. Corporate Identification No: L85195TG2002PLC039075 Regd. Office: 6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana, India. For more information, please visit www.vijayadiagnostic.com OR contact: Mr. Dhiren Gala Head of Investor Relations & Corporate Development Vijaya Diagnostic Centre Limited Tel: +91 90598 93206 Email: dhiren.g@vijayadiagnostic.in ir@vijayadiagnostic.in DISCLAIMER: Certain statements that may be made in the press release may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Vijaya Diagnostic Centre Limited will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances. Page | 2